Fact Sheet
Finding the Key: Innovative Funding Models for High-Cost Non-Communicable Diseases
In a global landscape study, 106 innovative funding solutions were identified with collaboration and knowledge sharing noted as the key success factors.
Dec 16, 2021
Download

The cost of cancer and high-cost chronic non-communicable diseases (NCDs) are significant and growing, posing an increasingly high burden of disease to health systems, businesses and individuals. Optimal patient outcomes are fundamentally linked to affordability and, despite meaningful efforts within the health system, current traditional funding models will struggle to close the funding gap.

This 'quick-view' infographic, produced by IQVIA and Roche, summarizes the key themes and concepts from the global landscape study, which identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia Pacific (APAC), Europe, Latin America (LATAM) and Middle East. The study aims to enable readers to better understand the possibilities of innovative funding while stressing the key success factors that enable sustainability and success, such as stakeholder collaboration.

To read the full white paper, click here.

This infographic was produced as part of a Innovative Funding Trends and Models Thought Leadership series, created by Roche and IQVIA in collaboration, in a bid to raise awareness of the new solutions and partnerships being used to finance healthcare across high burden diseases, such as cancers, neurological disease and rare diseases. To find out more, click here.

Contact Us